VAERS Explorer
Back to explore

Report #2835242

Received Apr 9, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
NY
Recovered
Not recovered
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
COVID19COVID19 (COVID19 (PFIZER-BIONTECH))PFIZER\BIONTECHUNK——

Symptoms (4)

COVID-19Disease recurrenceDrug ineffectivePost-acute COVID-19 syndrome

Symptom narrative

Debilitated by COVID-19 before; Debilitated by COVID-19 before; Severe long COVID-19 and had an acute infection right now; Long COVID-19; This is a spontaneous report received from a consumer, Program ID. A 39-year-old patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for COVID-19 immunisation. The patient's relevant medical history included: "Primary immune deficiency" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Debilitated by COVID-19 before"; POST-ACUTE COVID-19 SYNDROME (medically significant), outcome "not recovered", described as "Long COVID-19"; DISEASE RECURRENCE (medically significant), outcome "not recovered", described as "Severe long COVID-19 and had an acute infection right now". The patient had COVID-19 before and is very sick. The patient needs nirmatrelvir/ritonavir (PAXLOVID) and also has other medical issues. During an inbound call for financial assistance, the patient had a prescription for nirmatrelvir/ritonavir (PAXLOVID). The patient had very severe long COVID-19 and had an acute infection right now. The patient had very severe primary immune deficiency. The patient had been so debilitated by COVID-19 before. The patient asked if it is five days that's covered. The patient's doctor said that she could only write 5 days at a time cause some people with long COVID-19 they find nirmatrelvir/ritonavir helps them a lot, so they take it for 5 days and then they take it for 5 more days. The patient asked if the company knows anything about the vaccine injuries from the COVID-19 vaccine. The patient didn't know that nirmatrelvir/ritonavir was made by Pfizer and had a really severe reaction to the COVID-19 vaccine, so the patient was just curious.

Medical history

Medical History/Concurrent Conditions: Immunodeficiency